Compagnie Lombard Odier SCmA’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-150,000	Closed	-$72K	–	1022
2016 Q1	$72K	Sell	150,000 -61,110	-29%	-$26.7K	﹤0.01%	674
2015 Q4	$148K	Buy	211,110 +17,510	+9%	+$18.1K	﹤0.01%	532
2015 Q3	$246K	Sell	193,600 -36,000	-16%	-$42.1K	0.01%	381
2015 Q2	$252K	Buy	229,600 +5,000	+2%	+$7.5K	0.01%	406
2015 Q1	$464K	Buy	224,600 +11,000	+5%	+$22.6K	0.02%	319
2014 Q4	$318K	Buy	213,600 +26,000	+14%	+$46.4K	0.01%	330
2014 Q3	$437K	Buy	187,600 +111,600	+147%	+$426K	0.02%	353
2014 Q2	$347K	Buy	76,000 +5,000	+7%	+$21.6K	0.01%	409
2014 Q1	$314K	Buy	71,000 +16,000	+29%	+$82K	0.01%	406
2013 Q4	$260K	Buy	+55,000	New	+$270K	0.01%	464

Compagnie Lombard Odier SCmA's ALXA Position: Q2 2016 in Review

Compagnie Lombard Odier SCmA sold out of Alexza Pharmaceuticals Inc (ALXA) in Q2 2016, closing a stake of 150,000 shares — an estimated $72K sold.

Compagnie Lombard Odier SCmA first reported a position in ALXA in Q4 2013 and held it in 10 quarters. The position peaked at $464K in Q1 2015. 0 funds tracked by Wall St. Rank hold ALXA as of Q2 2016.

Compagnie Lombard Odier SCmA reported no remaining Alexza Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 150,000 Alexza Pharmaceuticals Inc shares in Q2 2016, an estimated $72K.
Compagnie Lombard Odier SCmA first reported a position in Alexza Pharmaceuticals Inc in Q4 2013 and held it in 10 quarters.
Compagnie Lombard Odier SCmA's Alexza Pharmaceuticals Inc position peaked at $464K in Q1 2015.
0 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q2 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2016, filed 15 Aug 2016.